Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus
- 1 September 2004
- journal article
- Published by Elsevier BV in Journal of Virological Methods
- Vol. 120 (1), 87-96
- https://doi.org/10.1016/j.jviromet.2004.04.009
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- SARS — beginning to understand a new virusNature Reviews Microbiology, 2003
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003
- The Genome Sequence of the SARS-Associated CoronavirusScience, 2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003
- Mass Spectrometric Characterization of Proteins from the SARS VirusMolecular & Cellular Proteomics, 2003
- Identification and Characterization of a Peptide That Specifically Binds the Human, Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody b12Journal of Virology, 2001
- Envelope glycoprotein interactions in coronavirus assembly.The Journal of cell biology, 1995
- Antigenic Structure of Transmissible Gastroenteritis Virus. I. Properties of Monoclonal Antibodies Directed against Virion ProteinsJournal of General Virology, 1986
- Reactivity of Human Coronavirus OC43 and Neonatal Calf Diarrhoea Coronavirus Membrane-associated AntigensJournal of General Virology, 1982
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975